Invizyne Technologies Announces Name Change to eXoZymes, Inc. and New Ticker Symbol
Invizyne Technologies, a designer of cell-free, enzyme-based biomanufacturing systems, announced its corporate name change to eXoZymes, Inc. The company, currently trading under NASDAQ ticker IZTC, will change its ticker symbol to EXOZ, expected to take effect on February 12, 2025, pending final approvals.
The company will update its branding, including the corporate website, to reflect the new name. Existing shareholders are not required to take any action regarding the name and ticker symbol change. The CUSIP number for the company's common stock will remain unchanged.
Invizyne Technologies, un designer di sistemi di biomanifattura basati su enzimi senza cellule, ha annunciato il cambio del suo nome aziendale in eXoZymes, Inc. La società, attualmente quotata con il ticker NASDAQ IZTC, cambierà il suo simbolo di ticker in EXOZ, che dovrebbe entrare in vigore il 12 febbraio 2025, in attesa delle approvazioni finali.
La società aggiornerà il suo branding, incluso il sito web aziendale, per riflettere il nuovo nome. Gli azionisti esistenti non sono tenuti a intraprendere alcuna azione riguardo al cambio di nome e simbolo di ticker. Il numero CUSIP per le azioni ordinarie della società rimarrà invariato.
Invizyne Technologies, un diseñador de sistemas de bioproducción basados en enzimas sin células, anunció su cambio de nombre corporativo a eXoZymes, Inc. La compañía, que actualmente cotiza bajo el símbolo NASDAQ IZTC, cambiará su símbolo de ticker a EXOZ, que se espera que entre en vigor el 12 de febrero de 2025, sujeto a las aprobaciones finales.
La empresa actualizará su marca, incluido el sitio web corporativo, para reflejar el nuevo nombre. Los accionistas existentes no necesitan realizar ninguna acción respecto al cambio de nombre y símbolo de ticker. El número CUSIP para las acciones ordinarias de la compañía permanecerá sin cambios.
Invizyne Technologies, 세포 없는 효소 기반 생물 제조 시스템의 설계자인 기업이 eXoZymes, Inc.로 상호 변경을 발표했습니다. 현재 NASDAQ 심볼 IZTC로 거래되는 이 회사는 심볼을 EXOZ로 변경할 예정이며, 이는 2025년 2월 12일에 발효될 것으로 예상됩니다(최종 승인 대기 중).
회사는 새로운 이름을 반영하기 위해 브랜드와 회사 웹사이트를 업데이트할 것입니다. 기존 주주들은 이름 및 ticker 심볼 변경에 대해 아무런 조치를 취할 필요가 없습니다. 회사의 보통주 CUSIP 번호는 변경되지 않습니다.
Invizyne Technologies, un concepteur de systèmes de biofabrication sans cellules basés sur des enzymes, a annoncé son changement de nom en eXoZymes, Inc. L'entreprise, actuellement cotée sous le symbole NASDAQ IZTC, changera son symbole de ticker en EXOZ, ce qui devrait entrer en vigueur le 12 février 2025, sous réserve des approbations finales.
L'entreprise mettra à jour son image de marque, y compris le site web de l'entreprise, pour refléter le nouveau nom. Les actionnaires existants ne sont pas tenus d'entreprendre des actions concernant le changement de nom et de symbole de ticker. Le numéro CUSIP pour les actions ordinaires de la société restera inchangé.
Invizyne Technologies, ein Hersteller von zellfreien, enzym-basierten Bioproduktionssystemen, hat seine Unternehmensnamensänderung in eXoZymes, Inc. bekannt gegeben. Das Unternehmen, das derzeit unter dem NASDAQ-Ticker IZTC gehandelt wird, wird sein Ticker-Symbol auf EXOZ ändern, was voraussichtlich am 12. Februar 2025 in Kraft treten wird, vorbehaltlich der endgültigen Genehmigungen.
Das Unternehmen wird sein Branding, einschließlich der Unternehmenswebsite, aktualisieren, um den neuen Namen widerzuspiegeln. Bestehende Aktionäre sind nicht verpflichtet, Maßnahmen bezüglich der Namens- und Ticker-Symboländerung zu ergreifen. Die CUSIP-Nummer für die Stammaktien des Unternehmens bleibt unverändert.
- None.
- None.
Trading Under New Ticker of “EXOZ” Expected to Begin February 12, 2025
Monrovia, CA, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Today, Invizyne Technologies, Inc., (NASDAQ: IZTC) ("Invizyne"), a leading designer of cell-free, enzyme-based biomanufacturing systems to produce commercially important molecules and chemicals for everyday life, announced a corporate name change to eXoZymes, Inc. (“eXoZymes”) and an application for a new ticker symbol. The company expects trading under the new ticker symbol of “EXOZ” to begin on February 12, 2025, subject to final approvals.
In connection with the corporate name change, Company branding, including the corporate website, will be updated accordingly.
No action is required by existing shareholders with respect to the name and ticker symbol change. The Committee on Uniform Securities Identification Procedures (CUSIP) also confirmed the CUSIP number assigned to the Company's common stock will remain unchanged.
About Invizyne
Invizyne Technologies, Inc. is a cell-free enzyme-based biomanufacturing technology company headquartered in Monrovia, California. Invizyne is redefining biomanufacturing by leveraging cell-free, multi-step, enzyme-based systems to efficiently transform natural or renewable resources into highly sought after biochemicals, such as Active Pharmaceutical Ingredients (APIs), biofuels, food flavors, fragrances, cosmetics, etc. Management of Invizyne believes that its biomanufacturing platform, will be a significant alternative to the current methods of chemical compound production, which are generally chemical synthesis, natural extraction, and synthetic biology.
For more information, please visit www.invizyne.com
Forward-Looking Statements
This press release contains "forward-looking statements." These forward-looking statements are made as of the date they were first issued and were based on current expectations, estimates, forecasts and projections as well as the beliefs and assumptions of management. Words such as “aim”, "expect," "anticipate," "should," "believe," "hope," "target," "project," "goals," "estimate," "potential," "predict," "may," "will," "might," "could," "intend," "shall" and variations of these terms or the negative of these terms and similar expressions are intended to identify these forward-looking statements.
Forward-looking statements are subject to a number of risks and uncertainties, many of which involve factors or circumstances that are beyond Invizyne's control. Invizyne's actual results could differ materially from those stated or implied in forward-looking statements due to a number of factors. The forward-looking statements included in this press release represent Invizyne's views as of the date of this press release. Invizyne anticipates that subsequent events and developments will cause its views to change. Invizyne undertakes no intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. These forward-looking statements should not be relied upon as representing Invizyne's views as of any date subsequent to the date of this press release.
Media contacts:
Lasse Görlitz, VP of Communications
(858) 319-7135
press@invizyne.com
Investor Relations Contact:
IR@invizyne.com
FAQ
When will Invizyne Technologies (IZTC) start trading under its new ticker EXOZ?
Do Invizyne Technologies (IZTC) shareholders need to take any action due to the name change?
Will the CUSIP number change with Invizyne's new name and ticker?
What is the new name for Invizyne Technologies (IZTC)?
